RxDoctor Payments Data

Norma Perales, MD

Family Medicine · Chandler, AZNPI 1457405953

Payments from drug & device makers

$1,590in general payments, 2019–2025

Across 79 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$276
  • Pfizer$133
  • Lilly USA, LLC$130
  • Abbott$126
  • Exact Sciences$121
  • Boston Scientific$102
  • plus $701 from 18 others

What the payments were for

  • Food & beverage$1,590100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,590 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$258,485
Medicare patients
449
Services billed
3,486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide75$78,405
JanuviaSitagliptin Phosphate46$61,669
JardianceEmpagliflozin31$43,360
EliquisApixaban27$38,850
Tresiba Flextouch U-100Insulin Degludec11$13,272
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$11,325
TrulicityDulaglutide12$11,239
PaxlovidNirmatrelvir/Ritonavir13$4,071
Duloxetine Hcl152$3,623
Atorvastatin Calcium299$3,342
Incruse ElliptaUmeclidinium Bromide11$3,144
SynthroidLevothyroxine Sodium28$2,826
Wixela InhubFluticasone Propion/Salmeterol25$2,794
SymbicortBudesonide/Formoterol Fumarate12$2,717
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,518

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$276$78,40575 claims
Boehringer IngelheimJardiance$19$43,36031 claims
PfizerEliquis, Paxlovid$133$42,92140 claims
AstraZenecaBreztri Aerosphere, Symbicort$57$14,04225 claims
Lilly USA, LLCTrulicity$130$11,23912 claims
GSKIncruse Ellipta$13$3,14411 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$22$2,344304 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →